BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36804838)

  • 1. Characterization of expression and prognostic implications of transforming growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma.
    Murphy JD; Shiomitsu K; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Axiak-Bechtel S
    Vet Immunol Immunopathol; 2023 Mar; 257():110560. PubMed ID: 36804838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of expression and prognostic implications of GD2 and GD3 synthase in canine histiocytic sarcoma.
    Murphy JD; Axiak-Bechtel S; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Shiomitsu K
    Vet Immunol Immunopathol; 2023 May; 259():110594. PubMed ID: 37058951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.
    Zhang L; Wang XI; Ding J; Sun Q; Zhang S
    Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.
    Engelien JL; Lejeune AT; Dark MJ; Milner RJ; Shiomitsu K
    Vet Med Sci; 2022 Jul; 8(4):1400-1408. PubMed ID: 35339118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
    Enkhbat T; Nishi M; Takasu C; Yoshikawa K; Jun H; Tokunaga T; Kashihara H; Ishikawa D; Shimada M
    Anticancer Res; 2018 Jun; 38(6):3367-3373. PubMed ID: 29848685
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhou LY; Xie Y; Li Y
    World J Gastroenterol; 2022 Jul; 28(26):3164-3176. PubMed ID: 36051332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible regulatory effect of the PD-1/PD-L1 signaling pathway on Tregs in ovarian cancer.
    Chen JX; Yi XJ; Gao SX; Sun JX
    Gen Physiol Biophys; 2020 Jul; 39(4):319-330. PubMed ID: 32902402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenteric lymph node CD11b
    Shiokawa A; Kotaki R; Takano T; Nakajima-Adachi H; Hachimura S
    Immunology; 2017 Sep; 152(1):52-64. PubMed ID: 28423181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
    Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
    Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Lymphocytes in Histiocytic Sarcomas of Flat-Coated Retriever Dogs.
    Marcinowska A; Constantino-Casas F; Williams T; Hoather T; Blacklaws B; Dobson J
    Vet Pathol; 2017 Jul; 54(4):605-610. PubMed ID: 28129095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1/PD-L1 regulates Treg differentiation in pregnancy-induced hypertension.
    Jiang L; Tang C; Gong Y; Liu Y; Rao J; Chen S; Qu W; Wu D; Lei L; Chen L
    Braz J Med Biol Res; 2018; 51(8):e7334. PubMed ID: 29846432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1
    Zhou L; Wang J; Lyu SC; Pan LC; Shi XJ; Du GS; He Q
    Technol Cancer Res Treat; 2021; 20():15330338211045820. PubMed ID: 34605709
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Zhou L; Liu D; Xie Y; Yao X; Li Y
    Gut Liver; 2019 Mar; 13(4):430-439. PubMed ID: 30600673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death 1/programmed cell death-ligand 1 pathway participates in gastric surgery-induced imbalance of T-helper 17/regulatory T cells in mice.
    Dong L; Zheng X; Wang K; Wang G; Zou H
    J Trauma Acute Care Surg; 2018 Sep; 85(3):549-559. PubMed ID: 29554041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.